Financials SELVAS Healthcare, Inc.

Equities

A208370

KR7208370007

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
4,945 KRW -1.00% Intraday chart for SELVAS Healthcare, Inc. +5.55% -27.60%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 42,334 43,491 54,252 64,973 45,264 175,241
Enterprise Value (EV) 1 62,693 50,023 57,262 66,854 46,036 154,201
P/E ratio -2.11 x -13 x 71.6 x 27.8 x 23.2 x 31.9 x
Yield - - - - - -
Capitalization / Revenue 2.11 x 1.95 x 2.56 x 2.23 x 1.63 x 5.88 x
EV / Revenue 3.13 x 2.24 x 2.71 x 2.3 x 1.66 x 5.17 x
EV / EBITDA -5.98 x -52.4 x 15.6 x 13.4 x 13.5 x 35.4 x
EV / FCF -25.9 x 10.2 x 21.9 x -754 x -68.9 x 104 x
FCF Yield -3.86% 9.84% 4.57% -0.13% -1.45% 0.96%
Price to Book 2.99 x 2.78 x 2.18 x 2.32 x 1.38 x 2.92 x
Nbr of stocks (in thousands) 13,147 14,007 21,658 21,658 21,658 25,658
Reference price 2 3,220 3,105 2,505 3,000 2,090 6,830
Announcement Date 3/21/19 3/18/20 3/12/21 3/16/22 3/16/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 20,026 22,351 21,152 29,089 27,686 29,813
EBITDA 1 -10,476 -954.5 3,672 4,998 3,422 4,360
EBIT 1 -13,112 -3,370 1,518 3,416 2,323 3,349
Operating Margin -65.47% -15.08% 7.18% 11.74% 8.39% 11.23%
Earnings before Tax (EBT) 1 -19,090 -3,989 745.1 2,537 2,689 3,858
Net income 1 -19,992 -3,328 758.7 2,472 2,650 5,170
Net margin -99.83% -14.89% 3.59% 8.5% 9.57% 17.34%
EPS 2 -1,523 -239.0 35.00 107.8 89.95 214.0
Free Cash Flow 1 -2,418 4,921 2,616 -88.63 -667.7 1,479
FCF margin -12.07% 22.02% 12.37% -0.3% -2.41% 4.96%
FCF Conversion (EBITDA) - - 71.23% - - 33.93%
FCF Conversion (Net income) - - 344.8% - - 28.61%
Dividend per Share - - - - - -
Announcement Date 3/21/19 3/18/20 3/12/21 3/16/22 3/16/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4
Net sales 1 7.883 6.732
EBITDA - -
EBIT 1 1.453 -0.4274
Operating Margin 18.43% -6.35%
Earnings before Tax (EBT) - -
Net income - -
Net margin - -
EPS - -
Dividend per Share - -
Announcement Date 11/14/23 3/20/24
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 20,360 6,532 3,010 1,881 771 -
Net Cash position 1 - - - - - 21,041
Leverage (Debt/EBITDA) -1.944 x -6.843 x 0.8197 x 0.3764 x 0.2254 x -
Free Cash Flow 1 -2,418 4,921 2,616 -88.6 -668 1,479
ROE (net income / shareholders' equity) -94.3% -17.2% 3.09% 9.33% 8.7% 11%
ROA (Net income/ Total Assets) -17.1% -4.77% 2.06% 4.54% 3.09% 3.71%
Assets 1 117,045 69,827 36,884 54,486 85,870 139,190
Book Value Per Share 2 1,078 1,115 1,149 1,296 1,519 2,342
Cash Flow per Share 2 109.0 598.0 445.0 456.0 203.0 383.0
Capex 1 677 133 138 371 352 360
Capex / Sales 3.38% 0.6% 0.65% 1.28% 1.27% 1.21%
Announcement Date 3/21/19 3/18/20 3/12/21 3/16/22 3/16/23 3/20/24
1KRW in Million2KRW
Estimates
  1. Stock Market
  2. Equities
  3. A208370 Stock
  4. Financials SELVAS Healthcare, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW